PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

BACKGROUND: Innovative prevention strategies for HIV-1 transmission are urgently needed. PRO2000 vaginal gel was efficacious against HIV-1 transmission in studies in macaques; we aimed to assess efficacy and safety of 2% and 0·5% PRO2000 gels against vaginal HIV-1 transmission in women in sub-Sahara...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: McCormack, Sheena, Ramjee, Gita, Kamali, Anatoli, Rees, Helen, Crook, Angela M, Gafos, Mitzy, Jentsch, Ute, Pool, Robert, Chisembele, Maureen, Kapiga, Saidi, Mutemwa, Richard, Vallely, Andrew, Palanee, Thesla, Sookrajh, Yuki, Lacey, Charles J, Darbyshire, Janet, Grosskurth, Heiner, Profy, Albert, Nunn, Andrew, Hayes, Richard, Weber, Jonathan
Médium: Artigo
Jazyk:Inglês
Vydáno: Lancet Publishing Group 2010
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956883/
https://ncbi.nlm.nih.gov/pubmed/20851460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(10)61086-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky